AMSTERDAM, September 28, 2015 /PRNewswire/ --
Highlights include connected sleep
solutions and the newest technology for COPD
management
Philips Respironics, a business of Royal Philips (NYSE: PHG,
AEX: PHIA), will showcase its latest portfolio of sleep-disordered
breathing and respiratory solutions September 26-29 at the European Respiratory
Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians
can experience the latest Philips sleep-disordered breathing
solutions and new options for COPD management that connect and
support the patient, clinician and caregiver to improve patient
care and help patients to live active lives.
Sleep: Patient-driven designs for successful
OSA treatment
Philips' sleep therapy portfolio connects the provider and the
patient at the most important points in the health continuum, from
diagnosis to compliance and ongoing use and resupply. The following
new sleep-disordered breathing solutions will be on display during
ERS 2015:
- Dream Family: The new, full integrated, patient-centric
sleep therapy solution from Philips featuring a connected positive
airway pressure (PAP) therapy device, complementary mask line, and
engagement tools to improve care for obstructive sleep apnea (OSA)
patients. The Dream Family integrated solution includes the
DreamStation PAP device, DreamWear mask, and
DreamMapper[1] personalized coaching tool. The Dream
Family, which will become available to patients and care teams in
select countries after October 2015,
is designed to engage patients in natural, comfortable and
effective sleep therapy while seamlessly connecting them to their
care teams for optimal therapy management.
- Amara View: A
minimal contact, full-face mask, the under-the-nose design of Amara
View prevents red marks, discomfort and irritation on the bridge of
the nose. It also offers the widest field of vision of leading full
face masks[2].
"As a leader in sleep apnea treatment innovation, Philips
continuously aims to expand its CPAP mask offerings with an
emphasis on patient comfort," said Mark
D'Angelo, Sleep Business Leader of Philips. "By addressing
patient concerns, like limited mobility and mask-related
irritation, we can provide patients with more personalized options
to help them adapt to and stick with their OSA treatment, and get
the sleep they deserve."
Respiratory: Comprehensive
COPD disease state
management solutions
Philips Respironics is committed to providing one unified
approach to COPD care - coordinated, consistent, uninterrupted and
centered around the patient and the home. Our goal is to help
reduce hospitalizations, improve patient care, maximize clinician
resources and support patients in living more active, fulfilling
lives.
Philips will display the following new respiratory solutions at
ERS 2015:
- SimplyGo Mini: With an attractive and sleek design and a
comfortable carrying case, SimplyGo Mini is a proven solution for
patients who struggle with respiratory disorders to continue living
full, active lives. The smallest and lightest portable oxygen
concentrator (POC) in the Philips portfolio, SimplyGo Mini delivers
nearly 20 percent more oxygen output than any POC weighing five
pounds or less[3].
- VitaBreath: VitaBreath is a small, lightweight
therapy support device for patients who experience dyspnea related
to their COPD[4]. The portable positive airway pressure
(PAP) device provides relief within two minutes and can reduce
breathlessness recovery time by up to 40
percent[5].
Driving discussion on core sleep and
respiratory trends and challenges
Philips executives will participate in the following workshops
and symposiums during ERS 2015, providing insight into
sleep-disordered breathing and respiratory care:
Practical Workshop: Sunday,
September 27, 1:15 - 2:30 p.m.
CET, Room E104-106 (E Area)
- Clinical Usefulness of AVAPS-AE, Nick Hart, BSc PhD MRCP FFICM,
Clinical and Academic Director, Lane Fox Respiratory Unit, Guy's
& St Thomas' NHS Foundation Trust and St Thomas' Hospital
- Application of AVAPS-AE to reduce hospital readmissions,
Michael Dreher, Global Head of
Operations and Customer Service at Philips Healthcare
Evening Symposium: Tuesday, September 29, 5:30 - 7:00 p.m. CET, Room 13.2 (Hall 13)
- PAP and the Heart: Benefit or Harm
- Chair: Dr. Teofilo Lee-Chiong,
Professor of Medicine, National Jewish Health, Denver
Speakers: Professor Dr. Winfried J.
Randerath, Germany;
Douglas Bradley, Canada
Visit Philips Respironics at 1.H_01, Hall 1 during the 2015 ERS
International Congress. For more information on Philips' advanced
solutions for sleep and respiratory care and for live updates from
ERS 2015, follow @PhilipsLiveFrom and the Philips ERS web site and
continue the conversation @PhilipsResp and the Philips Respironics
Facebook page.
About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA)
is a diversified health and well-being company, focused on
improving people's lives through meaningful innovation in the areas
of Healthcare, Consumer Lifestyle and Lighting. Headquartered in
the Netherlands, Philips posted
2014 sales of EUR 21.4 billion and
employs approximately 106,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care,
acute care and home healthcare, energy efficient lighting solutions
and new lighting applications, as well as male shaving and grooming
and oral healthcare. News from Philips is located at
http://www.philips.com/newscenter.
--------------------------------------------------
1. DreamMapper is currently in limited release and being piloted
in select markets
2. Data on file, Philips Respironics external and internal
testing
3. Data on file, Philips Respironics external and internal
testing
4. VitaBreath is currently pending 510(k) approval and is not
yet available for sale in the U.S.
5. Data on file, Philips Respironics external and internal
testing
For further information, please
contact:
Alicia Cafardi
Philips
alicia.cafardi@philips.com
+1-724-387-4439